Novel platform for live-imaging of cells in action

CYMOPLIVE – Cyto-Motility and Cyto-Plasticity in Vitro Live-Cell Assay About the technology Cymoplive is a platform that allows us to study cells in action and how they smartly tackle obstacles in our body. Cell movement or motility governs how cells migrate, invade, repair injuries, and develop tissues and organs. These processes are critical for a […]

SMOLTR – Synchronizing seawater readiness of salmon smolt with seawater transfer

About the technology SMOLTR is a smolt-verification tool to be utilized in the smoltification process of salmon. Data indicates that this technology is superior to current commercially available options, this robust tool will ensure long-term salmonid growth and welfare in seawater. SMOLTR is based on a set of superior and precise markers that can predict […]

Single-objective light-sheet imaging system (SOLIS)

Instant volume microscopy The SOLIS Microscope A new type of fluorescence microscope that combines the best aspects of confocal with light-sheet microscopy. SOLIS efficiently removes parasitic light from out-of-focus planes that would bleed through between adjacent focal planes and degrade image contrast. SOLIS is posed to fill this technology gap between methods that offer the […]

Spermotile – A sophisticated tool for improved fertilization success rate

Sperm filtration for improved success rate of assisted reproduction technology About the technology With current automated or manual IVF methods focusing on motility, the chance of identifying a sperm for fertilization is high, but the likelihood of the selected sperm being the best is small. This means an inaccurate quality analysis that takes a toll […]

New therapeutic for liver disease, NASH

An unmet medical need Non-alcoholic steatohepatitis (NASH) is an advanced form of fatty liver disease that is expected to become the major cause of liver transplantation in the US by 2025. There is an enormous unmet medical need to treat the disease because of its high prevalence and lack of treatment options: there are currently […]

MicroRNAs for reduced bleeding risk in Venous thromboembolism patients

– MicroRNAs for risk assessment and treatment of venous thromboembolism The challenge Venous thromboembolism (VTE) is a highly prevalent disease, affecting around 1.1 million individuals in Europe each year, with 540,000 associated deaths. No modifiable risk-factors have been identified yet. The current anti-coagulant treatment is associated with serious bleeding risks. We therefore need to find […]